| Medical Mutual | Mepsevii® (vestronidase alfa-vjbk) (Intravenous) | 2025-04-07 |
| Medical Mutual | Naglazyme® (galsulfase) (Intravenous) | 2025-04-07 |
| Medical Mutual | Nexviazyme® (avalglucosidase alfa-ngpt) (Intravenous) | 2025-04-07 |
| Medical Mutual | Vimizim (elosulfase alfa) (Intravenous) | 2025-04-07 |
| Medical Mutual | VPRIV® (velaglucerase alfa) (Intravenous) | 2025-04-07 |
| Medical Mutual | Vyxeos® (daunorubicin and cytarabine – liposome) (Intravenous) | 2025-04-07 |
| Medical Mutual | Xenpozyme® (olipudase alfa) (Intravenous) | 2025-04-07 |
| Medical Mutual | Ziihera® (zanidatamab-hrii) (Intravenous) | 2025-04-07 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Opioid Dependence Therapy | 2025-04-07 |
| Medicare FCSO | Billing and Coding: Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor (57884) | 2025-04-04 |